20,000 Shares in Heron Therapeutics, Inc. (NASDAQ:HRTX) Acquired by Focus Partners Wealth
Focus Partners Wealth purchased a new position in shares of Heron Therapeutics, Inc. (NASDAQ:HRTX – Free Report) during the fourth quarter, HoldingsChannel.com reports. The institutional investor purchased 20,000 shares of the biotechnology company’s stock, valued at approximately $31,000. Several other large investors have also recently bought and sold shares of the company. Cornerstone Select Advisors […]
Focus Partners Wealth purchased a new position in shares of Heron Therapeutics, Inc. (NASDAQ:HRTX – Free Report) during the fourth quarter, HoldingsChannel.com reports. The institutional investor purchased 20,000 shares of the biotechnology company’s stock, valued at approximately $31,000. Several other large investors have also recently bought and sold shares of the company. Cornerstone Select Advisors […]
